APA (7th ed.) Citation

Xinyao Hu, Dan Li, Hua Zhu, Tao Yu, Xiaoxing Xiong, & Ximing Xu. (2023). ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma. BMC.

Chicago Style (17th ed.) Citation

Xinyao Hu, Dan Li, Hua Zhu, Tao Yu, Xiaoxing Xiong, and Ximing Xu. ATP6V1F Is a Novel Prognostic Biomarker and Potential Immunotherapy Target for Hepatocellular Carcinoma. BMC, 2023.

MLA (9th ed.) Citation

Xinyao Hu, et al. ATP6V1F Is a Novel Prognostic Biomarker and Potential Immunotherapy Target for Hepatocellular Carcinoma. BMC, 2023.